TY - JOUR
T1 - NH2-terminal probrain natriuretic peptide and risk of diabetes
AU - Lazo, Mariana
AU - Young, J. Hunter
AU - Brancati, Frederick L.
AU - Coresh, Josef
AU - Whelton, Seamus
AU - Ndumele, Chiadi E.
AU - Hoogeveen, Ron
AU - Ballantyne, Christie M.
AU - Selvin, Elizabeth
PY - 2013/9
Y1 - 2013/9
N2 - Brain natriuretic peptide (BNP) has an established role in cardiovascular disease (CVD). However, recent animal studies suggest direct metabolic effects of BNP. To determine the association of BNP with the risk of diabetes, we conducted a prospective analysis of participants from the Atherosclerosis Risk in Communities (ARIC) study. We included 7,822 men and women without history of diabetes, CVD, or reduced kidney function at baseline. At baseline, NH2-terminal (NT)-proBNP, a cleavage product of BNP, was inversely associated with adiposity, fasting glucose, insulin, and cholesterol but positively associated with blood pressure and C-reactive protein levels. During a median follow-up of 12 years, 1,740 participants reported a new diagnosis of diabetes or medication use for diabetes. Baseline quartiles of NT-proBNP were inversely associated with diabetes risk, even after multivariable adjustment including fasting glucose. The adjusted HRs for diabetes were 1.0 (reference), 0.84 (95% CI 0.740.96), 0.79 (95% CI 0.680.90), and 0.75 (95% CI 0.640.87) for the 1st, 2nd, 3rd, and 4th quartiles of baseline NT-proBNP, respectively (P for trend,0.001). This inverse association was robust across sex, race, and obesity subgroups. Our results extend animal studies and support a direct and important metabolic role of BNP in humans.
AB - Brain natriuretic peptide (BNP) has an established role in cardiovascular disease (CVD). However, recent animal studies suggest direct metabolic effects of BNP. To determine the association of BNP with the risk of diabetes, we conducted a prospective analysis of participants from the Atherosclerosis Risk in Communities (ARIC) study. We included 7,822 men and women without history of diabetes, CVD, or reduced kidney function at baseline. At baseline, NH2-terminal (NT)-proBNP, a cleavage product of BNP, was inversely associated with adiposity, fasting glucose, insulin, and cholesterol but positively associated with blood pressure and C-reactive protein levels. During a median follow-up of 12 years, 1,740 participants reported a new diagnosis of diabetes or medication use for diabetes. Baseline quartiles of NT-proBNP were inversely associated with diabetes risk, even after multivariable adjustment including fasting glucose. The adjusted HRs for diabetes were 1.0 (reference), 0.84 (95% CI 0.740.96), 0.79 (95% CI 0.680.90), and 0.75 (95% CI 0.640.87) for the 1st, 2nd, 3rd, and 4th quartiles of baseline NT-proBNP, respectively (P for trend,0.001). This inverse association was robust across sex, race, and obesity subgroups. Our results extend animal studies and support a direct and important metabolic role of BNP in humans.
UR - http://www.scopus.com/inward/record.url?scp=84887363815&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84887363815&partnerID=8YFLogxK
U2 - 10.2337/db13-0478
DO - 10.2337/db13-0478
M3 - Article
C2 - 23733199
AN - SCOPUS:84887363815
SN - 0012-1797
VL - 62
SP - 3189
EP - 3193
JO - Diabetes
JF - Diabetes
IS - 9
ER -